New Jersey Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 111 - 120 of 768
RSS Feed | View as table
CELGENE CORPORATION v. DEVA HOLDING A.S.
as 2:2023cv02992
Plaintiff: CELGENE CORPORATION
Defendant: DEVA HOLDING A.S.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. HIKMA PHARMACEUTICALS USA INC. et al
as 2:2023cv02942
Plaintiff: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant: HIKMA PHARMACEUTICALS USA INC., WEST-WARD COLUMBUS INC. and HIKMA PHARMACEUTICALS PLC
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. HIKMA PHARMACEUTICALS USA INC.
as 1:2023cv02942
Plaintiff: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant: HIKMA PHARMACEUTICALS USA INC., WEST-WARD COLUMBUS INC. and HIKMA PHARMACEUTICALS PLC
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. ALKEM LABORATORIES LTD. et al
as 2:2023cv02939
Plaintiff: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant: ALKEM LABORATORIES LTD. and ASCEND LABORATORIES, LLC
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. SANDOZ INC.
as 2:2023cv02943
Plaintiff: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant: SANDOZ INC.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. SANDOZ INC.
as 1:2023cv02943
Counter Defendant: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant: SANDOZ INC.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. ALKEM LABORATORIES LTD.
as 1:2023cv02939
Counter Defendant: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Counter Claimant: ALKEM LABORATORIES LTD.
Defendant: ASCEND LABORATORIES, LLC
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
BRAINTREE LABORATORIES, INC. et al v. LUPIN LIMITED et al
as 2:2023cv02853
Plaintiff: BRAINTREE LABORATORIES, INC. and SEBELA US INC.
Defendant: LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BRAINTREE LABORATORIES, INC. et al v. LUPIN LIMITED et al
as 1:2023cv02853
Plaintiff: BRAINTREE LABORATORIES, INC. and SEBELA US INC.
Defendant: LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
as 1:2023cv02843
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?